Skip Navigation


BJA Advance Access originally published online on March 27, 2006
British Journal of Anaesthesia 2006 96(5):583-586; doi:10.1093/bja/ael075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/5/583    most recent
ael075v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Imani, F.
Right arrow Articles by Khan, Z. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imani, F.
Right arrow Articles by Khan, Z. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Propofol–alfentanil vs propofol–remifentanil for posterior spinal fusion including wake-up test

F. Imani1,*, A. Jafarian2, V. Hassani1 and Z. H. Khan3

1 Department of Anaesthesiology, Rasool-Akram Hospital, School of Medicine, Iran University of Medical Sciences Tehran, Iran
2 Department of Anaesthesiology, Shafa-Yahyaeian Hospital, School of Medicine, Iran University of Medical Sciences Tehran, Iran
3 Department of Anaesthesiology, Imam Khomeini Medical Center, School of Medicine, Tehran University of Medical Sciences Tehran, Iran

*Corresponding author. E-mail: farimani{at}iums.ac.ir

Background. Wake-up test can be used during posterior spinal fusion (PSF) to ensure that spinal function remains intact. This study aims at assessing the characteristics of the wake-up test during propofol–alfentanil (PA) vs propofol–remifentanil (PR) infusions for PSF surgery.

Methods. Sixty patients with scoliosis and candidates for PSF surgery were randomly allocated in either alfentanil (PA) or remifentanil (PR) group. After an i.v. bolus of alfentanil 30 µg kg–1 in the PA group or remifentanil 1 µg kg–1 in the PR group, anaesthesia was induced with thiopental and atracurium. During maintenance, opioid infusion consisted of alfentanil 1 µg kg–1 min–1 or remifentanil 0.2 µg kg–1 min–1, in the PA group and the PR group, respectively. All patients received propofol 50 µg kg–1 min–1. Atracurium was given to maintain the required surgical relaxation. At the surgeon's request, all infusions were discontinued. Patients were asked to move their hands and feet. Time from anaesthetic discontinuation to spontaneous ventilation (T1), and from then until movement of the hands and feet (T2), and its quality were recorded.

Results. The average T1 and T2 were significantly shorter in the PR group [3.6 (2.5) and 4.1 (2) min] than the PA group [6.1 (4) and 7.5 (4.5) min]. Quality of wake-up test, however, did not show significant difference between the two groups studied.

Conclusion. Wake-up test can be conducted faster with remifentanil compared with alfentanil infusion during PSF surgery.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.